463 related articles for article (PubMed ID: 26454858)
1. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
Barros X; Rodríguez NY; Fuster D; Rodas L; Esforzado N; Mazza A; Rubello D; Campos F; Tapias A; Torregrosa JV
J Nephrol; 2016 Oct; 29(5):703-9. PubMed ID: 26454858
[TBL] [Abstract][Full Text] [Related]
2. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D treatment in hemodialysis patients with low serum levels of parathyroid hormone: which is the best choice?
Lomonte C; Casucci F; Libutti P; Losurdo N; Teutonico A; Basile C
J Nephrol; 2010; 23(2):210-5. PubMed ID: 20175051
[TBL] [Abstract][Full Text] [Related]
4. On-line haemodiafiltration improves response to calcifediol treatment.
Pérez-García R; Albalate M; de Sequera P; Alcázar R; Puerta M; Ortega M; Corchete E
Nefrologia; 2012 Jul; 32(4):459-66. PubMed ID: 22652556
[TBL] [Abstract][Full Text] [Related]
5. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
Minisola S; Cianferotti L; Biondi P; Cipriani C; Fossi C; Franceschelli F; Giusti F; Leoncini G; Pepe J; Bischoff-Ferrari HA; Brandi ML
Osteoporos Int; 2017 Nov; 28(11):3239-3249. PubMed ID: 28815282
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
[TBL] [Abstract][Full Text] [Related]
7. Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients.
Bañón S; Rosillo M; Gómez A; Pérez-Elias MJ; Moreno S; Casado JL
Endocrine; 2015 Jun; 49(2):528-37. PubMed ID: 25432490
[TBL] [Abstract][Full Text] [Related]
8. Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
Sprague SM; Silva AL; Al-Saghir F; Damle R; Tabash SP; Petkovich M; Messner EJ; White JA; Melnick JZ; Bishop CW
Am J Nephrol; 2014; 40(6):535-45. PubMed ID: 25572630
[TBL] [Abstract][Full Text] [Related]
9. Risk in dosing regimens for 25-OH vitamin D supplementation in chronic haemodialysis patients.
Albalate M; de la Piedra C; Ortiz A; Hernández Pérez J; Rubert M; Pérez Garcia R; Zazo P; Nieto L; de Sequera P; Egido J
Nephron Clin Pract; 2012; 121(3-4):c112-9. PubMed ID: 23221739
[TBL] [Abstract][Full Text] [Related]
10. Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients.
Das S; Bopitya S; Chowdhury AR; Das A; Taha H
Recent Pat Antiinfect Drug Discov; 2016; 11(1):59-67. PubMed ID: 26844688
[TBL] [Abstract][Full Text] [Related]
11. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
[TBL] [Abstract][Full Text] [Related]
12. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Short-Term Vitamin D Supplementation on Calcium Status in Vitamin D Insufficient Renal Transplant Recipients at Risk of Hypercalcemia.
Lynch Cronin I; Byrne F; Doyle R; Fraser WD; Chipchase A; Eustace JA
J Ren Nutr; 2019 May; 29(3):181-187. PubMed ID: 30691727
[TBL] [Abstract][Full Text] [Related]
14. Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.
Catalano A; Morabito N; Basile G; Cucinotta D; Lasco A
Eur J Clin Invest; 2015 Feb; 45(2):144-9. PubMed ID: 25483366
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and dose-response effects of calcifediol supplementation on 25-hydroxyvitamin D, parathyroid hormone, and 1,25-dihydroxyvitamin D levels in healthy adults: An open-label, interventional pilot study.
Das L; Holick MF; Sachdeva N; Bhadada SK; Singhmar S; Thakur N; Dutta P; Marwaha RK
Indian J Pharmacol; 2023; 55(5):286-292. PubMed ID: 37929406
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
Zitt E; Sprenger-Mähr H; Mündle M; Lhotta K
BMC Nephrol; 2015 Aug; 16():128. PubMed ID: 26238347
[TBL] [Abstract][Full Text] [Related]
18. Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD.
Levin A; Tang M; Perry T; Zalunardo N; Beaulieu M; Dubland JA; Zerr K; Djurdjev O
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1447-1460. PubMed ID: 28550081
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Change in Total and Free 25-Hydroxyvitamin D With 24,25-Dihydroxyvitamin D and Parathyroid Hormone.
Shieh A; Ma C; Chun RF; Wittwer-Schegg J; Swinkels L; Huijs T; Wang J; Donangelo I; Hewison M; Adams JS
J Clin Endocrinol Metab; 2018 Sep; 103(9):3368-3375. PubMed ID: 29931358
[TBL] [Abstract][Full Text] [Related]
20. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
Trials; 2014 Nov; 15():430. PubMed ID: 25376735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
